Alió JL, Shabayek MH Corneal higher order aberrations: a method to grade keratoconus. J Refract Surg. 2006 Jun;22(6):539-45.
Ambrósio R Jr, Alonso RS, Luz A, Coca Velarde LG Corneal-thickness spatial profile and corneal-volume distribution: tomographic indices to detect keratoconus. J Cataract Refract Surg. 2006 Nov;32(11):1851-9.
Bae GH, Kim JR, Kim CH, Lim DH, Chung ES, Chung TY Corneal topographic and tomographic analysis of fellow eyes in unilateral keratoconus patients using Pentacam. Am J Ophthalmol. 2014 Jan;157(1):103-109.e1. doi: 10.1016/j.ajo.2013.08.014.
Balasubramanian SA, Mohan S, Pye DC, Willcox MD Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus. Acta Ophthalmol. 2012 Jun;90(4):e303-9. doi: 10.1111/j.1755-3768.2011.02369.x.
Balasubramanian SA, Pye DC, Willcox MD Are proteinases the reason for keratoconus? Curr Eye Res. 2010 Mar;35(3):185-91. doi: 10.3109/02713680903477824. Review.
Beckh U, Schönherr U, Naumann GO [Autosomal dominant keratoconus as the chief ocular symptom in Lobstein osteogenesis imperfecta tarda]. Klin Monbl Augenheilkd. 1995 Apr;206(4):268-72. German.
Chan S, Freund PR, MacDonald I Advances in the genetics of eye diseases. Curr Opin Pediatr. 2013 Dec;25(6):645-52. doi: 10.1097/MOP.0000000000000026. Review.
Chen D, Lam AK Intrasession and intersession repeatability of the Pentacam system on posterior corneal assessment in the normal human eye. J Cataract Refract Surg. 2007 Mar;33(3):448-54.
Driver PJ, Reed JW, Davis RM Familial cases of keratoconus associated with posterior polymorphous dystrophy. Am J Ophthalmol. 1994 Aug 15;118(2):256-7.
Gatinel D, Malet J, Hoang-Xuan T, Azar DT Corneal elevation topography: best fit sphere, elevation distance, asphericity, toricity, and clinical implications. Cornea. 2011 May;30(5):508-15. doi: 10.1097/ICO.0b013e3181fb4fa7.
Greenstein SA, Fry KL, Bhatt J, Hersh PS Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg. 2010 Dec;36(12):2105-14. doi: 10.1016/j.jcrs.2010.
Grzybowski A, McGhee CN The early history of keratoconus prior to Nottingham's landmark 1854 treatise on conical cornea: a review. Clin Exp Optom. 2013 Mar;96(2):140-5. doi: 10.1111/cxo.12035. Review.
Gunes A, Tok L, Tok Ö, Seyrek L The Youngest Patient with Bilateral Keratoconus Secondary to Chronic Persistent Eye Rubbing. Semin Ophthalmol. 2015;30(5-6):454-6. doi: 10.3109/08820538.2013.874480.
Hughes AE, Dash DP, Jackson AJ, Frazer DG, Silvestri G Familial keratoconus with cataract: linkage to the long arm of chromosome 15 and exclusion of candidate genes. Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5063-6.
Kamiya K, Ishii R, Shimizu K, Igarashi A Evaluation of corneal elevation, pachymetry and keratometry in keratoconic eyes with respect to the stage of Amsler-Krumeich classification. Br J Ophthalmol. 2014 Apr;98(4):459-63. doi: 10.1136/bjophthalmol-2013-3
Kara N, Altinkaynak H, Baz O, Goker Y Biomechanical evaluation of cornea in topographically normal relatives of patients with keratoconus. Cornea. 2013 Mar;32(3):262-6. doi: 10.1097/ICO.0b013e3182490924.
Karolak JA, Gajecka M Genomic strategies to understand causes of keratoconus. Mol Genet Genomics. 2016 Dec 28. doi: 10.1007/s00438-016-1283-z. [Epub ahead of print] Review.
Li X, Yang H, Rabinowitz YS Longitudinal study of keratoconus progression. Exp Eye Res. 2007 Oct;85(4):502-7.
Lim L, Wei RH, Chan WK, Tan DT Evaluation of keratoconus in Asians: role of Orbscan II and Tomey TMS-2 corneal topography. Am J Ophthalmol. 2007 Mar;143(3):390-400.
Matthews FJ, Cook SD, Majid MA, Dick AD, Smith VA Changes in the balance of the tissue inhibitor of matrix metalloproteinases (TIMPs)-1 and -3 may promote keratocyte apoptosis in keratoconus. Exp Eye Res. 2007 Jun;84(6):1125-34.
McGhee CN 2008 Sir Norman McAlister Gregg Lecture: 150 years of practical observations on the conical cornea--what have we learned? Clin Exp Ophthalmol. 2009 Mar;37(2):160-76. doi: 10.1111/j.1442-9071.2009.02009.x.
Mok JW, Baek SJ, Joo CK VSX1 gene variants are associated with keratoconus in unrelated Korean patients. J Hum Genet. 2008;53(9):842-9. doi: 10.1007/s10038-008-0319-6.
Ortak H, Sögüt E, Tas U, Mesci C, Mendil D The relation between keratoconus and plasma levels of MMP-2, zinc, and SOD. Cornea. 2012 Sep;31(9):1048-51. doi: 10.1097/ICO.0b013e318254c028.
Rose NJ, Mackay K, Byers PH, Dalgleish R A Gly238Ser substitution in the alpha 2 chain of type I collagen results in osteogenesis imperfecta type III. Hum Genet. 1995 Feb;95(2):215-8.
Saad A, Gatinel D Evaluation of total and corneal wavefront high order aberrations for the detection of forme fruste keratoconus. Invest Ophthalmol Vis Sci. 2012 May 17;53(6):2978-92. doi: 10.1167/iovs.11-8803.
Semina EV, Mintz-Hittner HA, Murray JC Isolation and characterization of a novel human paired-like homeodomain-containing transcription factor gene, VSX1, expressed in ocular tissues. Genomics. 2000 Jan 15;63(2):289-93.
Sherwin T, Brookes NH Morphological changes in keratoconus: pathology or pathogenesis. Clin Exp Ophthalmol. 2004 Apr;32(2):211-7. Review.
Stabuc-Silih M, Strazisar M, Hawlina M, Glavac D Absence of pathogenic mutations in VSX1 and SOD1 genes in patients with keratoconus. Cornea. 2010 Feb;29(2):172-6. doi: 10.1097/ICO.0b013e3181aebf7a.
Sugar J, Macsai MS What causes keratoconus? Cornea. 2012 Jun;31(6):716-9. doi: 10.1097/ICO.0b013e31823f8c72. Review.
Swartz T, Marten L, Wang M Measuring the cornea: the latest developments in corneal topography. Curr Opin Ophthalmol. 2007 Jul;18(4):325-33. Review.
Tai LY, Khaw KW, Ng CM, Subrayan V Central corneal thickness measurements with different imaging devices and ultrasound pachymetry. Cornea. 2013 Jun;32(6):766-71. doi: 10.1097/ICO.0b013e318269938d.
Uçakhan ÖÖ, Cetinkor V, Özkan M, Kanpolat A Evaluation of Scheimpflug imaging parameters in subclinical keratoconus, keratoconus, and normal eyes. J Cataract Refract Surg. 2011 Jun;37(6):1116-24. doi: 10.1016/j.jcrs.2010.12.049.
Vazirani J, Basu S Keratoconus: current perspectives. Clin Ophthalmol. 2013;7:2019-30. doi: 10.2147/OPTH.S50119. Review.
Wagner H, Barr JT, Zadnik K Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date. Cont Lens Anterior Eye. 2007 Sep;30(4):223-32.
Wang Y, Rabinowitz YS, Rotter JI, Yang H Genetic epidemiological study of keratoconus: evidence for major gene determination. Am J Med Genet. 2000 Aug 28;93(5):403-9.
Wegener A, Laser-Junga H Photography of the anterior eye segment according to Scheimpflug's principle: options and limitations - a review. Clin Exp Ophthalmol. 2009 Jan;37(1):144-54. doi: 10.1111/j.1442-9071.2009.02018.x. Review.
Wilson SE, He YG, Weng J, Li Q, McDowall AW, Vital M, Chwang EL Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res. 1996 Apr;62(4)
Wollensak G, Spoerl E, Seiler T Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003 May;135(5):620-7.
Zelko IN, Mariani TJ, Folz RJ Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002 Aug 1;33(3):337-49. Review.
Evaluation of Tomographic and Genetic Aspects of Keratoconus Patients Compared to Sounds Corneas
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.